Filing search / Day One Biopharmaceuticals, Inc. / "Independent" / Page 5

8-K

EX-99.1

dlvwhvbsh18g6

24 Jun 22

Submission of Matters to a Vote of Security Holders

4:06pm

8-K

EX-1.1

ophz uavkdd8

16 Jun 22

Day One Announces Pricing of Upsized Public Offering of Common Stock

7:33am

424B5

32raub

16 Jun 22

Prospectus supplement for primary offering

7:30am

424B5

wwonpi a5gdujc41q

14 Jun 22

Prospectus supplement for primary offering

7:39am

8-K

EX-99.2

89o206dhcu zhgi

13 Jun 22

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

6:24am

8-K

EX-99.1

99ne bwyampwf3jd

13 Jun 22

Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma

6:24am

S-3

EX-1.2

70nckj

1 Jun 22

Shelf registration

4:06pm

S-3

EX-23.1

vziqt8zt00sgl 8j

1 Jun 22

Shelf registration

4:06pm

S-3

EX-4.4

mpiyfxw1emhq2la7mn1e

1 Jun 22

Shelf registration

4:06pm

S-3

EX-5.1

dokqiyso

1 Jun 22

Shelf registration

4:06pm

S-3

krfhyy2xncw

1 Jun 22

Shelf registration

4:06pm

8-K

EX-99.2

m9o5lnni7vel7wqkgl6

12 May 22

Day One Reports First Quarter 2022 Financial Results and Provides Business Update

4:33pm

DEF 14A

9ciusst

28 Apr 22

Definitive proxy

4:44pm

8-K

EX-99.1

kejyjtpgd0y9yci

13 Apr 22

Targeted Therapies for People of All Ages April 2022

8:01am

S-8

EX-23.2

v9gwt6fq1 kemg4l

7 Mar 22

Registration of securities for employees

4:31pm

S-8

7qzu8eq 483zztk

7 Mar 22

Registration of securities for employees

4:31pm

10-K

EX-10.2

jal2bvfg30mru

7 Mar 22

Annual report

7:36am

10-K

j4c0m

7 Mar 22

Annual report

7:36am

10-K

EX-23.1

l56vo8ml1 icr

7 Mar 22

Annual report

7:36am